Table 2.
Persistence
|
Switch
|
|||||
---|---|---|---|---|---|---|
OR | 95% CI | p-Value | OR | 95% CI | p-Value | |
Male | 1.073 | 0.653–1.761 | 0.782 | 1.268 | 0.692–2.323 | 0.441 |
Age | 1.000 | 0.985–1.016 | 0.970 | 0.990 | 0.971–1.010 | 0.335 |
CCI | 0.934 | 0.824–1.060 | 0.291 | 1.110 | 0.951–1.296 | 0.185 |
Drug dose escalation | 0.848 | 0.452–1.591 | 0.608 | 2.751 | 1.404–5.389 | 0.003 |
Drug dose reduction | 0.855 | 0.469–1.558 | 0.609 | 1.631 | 0.780–3.409 | 0.194 |
Etanercept | ref. | ref. | ||||
Adalimumab | 0.511 | 0.317–0.822 | 0.006 | 2.066 | 1.103–3.867 | 0.023 |
Infliximab | 0.759 | 0.428–1.348 | 0.347 | 1.714 | 0.823–3.572 | 0.150 |
Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval; CCI, Charlson Comorbidity Index.